Prognostic DNA methylation markers for renal cell carcinoma: a systematic review.

@article{Joosten2017PrognosticDM,
  title={Prognostic DNA methylation markers for renal cell carcinoma: a systematic review.},
  author={S. Joosten and I. Deckers and M. Aarts and A. Hoeben and J. V. van Roermund and K. Smits and V. Melotte and M. van Engeland and V. Tjan-Heijnen},
  journal={Epigenomics},
  year={2017},
  volume={9 9},
  pages={
          1243-1257
        }
}
AIM Despite numerous published prognostic methylation markers for renal cell carcinoma (RCC), none of these have yet changed patient management. Our aim is to systematically review and evaluate the literature on prognostic DNA methylation markers for RCC. MATERIALS & METHODS We conducted an exhaustive search of PubMed, EMBASE and MEDLINE up to April 2017 and identified 49 publications. Studies were reviewed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses… Expand
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers
DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis.
DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma
The Role of DNA Methylation in Renal Cell Carcinoma
...
1
2
3
...

References

SHOWING 1-10 OF 79 REFERENCES
Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
...
1
2
3
4
5
...